Breaking News
Sort by:
Top Post
ProBioGen and ImmunOs Therapeutics Team Up to Deliver Innovative Therapy for Cancer Patients
ProBioGen, a Berlin-based specialist for developing and manufacturing biopharmaceutical active ingredients, viral vectors and vaccines, and […]
Nemysis and Faran S.A. Sign Agreement to Cooperate for the Development of Endopeptidase E40 for Celiac Disease
Nemysis Ltd has announced a Strategic Cooperation with Faran S.A., a leading Greek pharma company, […]
Sonrava Health Enters Strategic Alliance with FCL Dental, Owner of One of the Nation’s Largest Independent Dental Benefits Companies
Sonrava Health has announced that it has entered into a strategic alliance with FCL Dental, […]
Babyl & Novo Nordisk Partner to Provide an Innovative Approach to Diabetes Awareness and Care in Rwanda
Babyl, a subsidiary of Babylon, and Novo Nordisk announced today that they have entered an […]
UpStream and Tidewater Physicians Multispecialty Group Announce Partnership
UpStream, a value-based management services organization based in Greensboro, NC with a unique model of […]
Turnstone Biologics Enters Cooperative Research and Development Agreement with the National Cancer Institute
Turnstone Biologics Corp, a clinical-stage biotechnology company developing next-generation immunotherapies to treat and cure solid […]
TargEDys and SymbioPharm Enter an Exclusive Partnership to launch SymbioLife® Satylia® in Germany
TargEDys and SymbioPharm signed an exclusive marketing and distribution agreement for the launch of SymbioLife® […]
Full-Life Technologies to Acquire Focus-X Therapeutics, Bolstering Peptide-Focused Radiopharmaceutical Pipeline
Full-Life Technologies, a fully integrated global radiotherapeutics company, today announced an agreement to acquire New Jersey-based […]
Medcase & NTT DATA Sign a Definitive Agreement to Enable Healthcare AI Developers a Holistic Solution
Medcase, a leading solution provider for healthcare AI, and NTT DATA, a digital business and IT […]
Biocytogen Enters into Antibody Agreement with ADC Therapeutics
Biocytogen Pharmaceuticals has announced that it has entered into an evaluation and option agreement with […]
Brainomix Announces New Partnership with Pixyl to Expand its Offering with Multiple Sclerosis Solution
Brainomix, an AI-powered medtech solutions company, has announced a new partnership with Pixyl, an award-winning, […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more